Free Cash Flow

TRxADE HEALTH, Inc. (MEDS)

$ 4.5
-0.51 (-10.18%)

Free Cash Flow

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.961.502.912.482.933.837.4417.1227.1443.0268.19108.09171.32
Revenue (%)
Operating Cash Flow -0.84-1.06-1.97-1.310.170.270.14-2.21-9.44-14.96-23.72-37.59-59.59
Operating Cash Flow (%)
Capital Expenditure -0.01-0.02-0.03-0.03-0.03-0.04-0.09-0.20-0.31-0.49-0.78-1.24-1.97
Capital Expenditure (%)
Free Cash Flow -0.86-1.08-2.01-1.340.140.230.06-2.41-9.75-15.46-24.50-38.83-61.55

FCF Unlevered from cash flow statement